 | Up a level |
Brueckl, W. M., Wirtz, R. M., Bertsch, T., Ficker, J. H. and Jung, A. (2017). Liquid Biopsy: Detection of Molecular Markers for Treatment Decisions in Lung Cancer. Pneumologie, 71 (3). S. 151 - 164. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Dahl, E., Jung, A., Fassunke, J., Hummel, M., Penzel, R., Dietmaier, W. and Lassmann, S. (2015). Chances and Risks of blood-based molecular pathological Analysis of circulating Tumor Cells (CTC) and cell free DNA (cfDNA) in personalized Cancer Therapy A Statement of the Working Group Liquid Biopsy of the AG Molecular Pathology ini the German Society for Pathology (DGP). Pathologe, 36 (1). S. 92 - 98. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1963
Dietmaier, W., Merkelbach-Bruse, S., Jung, A. and Lehmann, U. (2016). Report on sessions and the general meeting of the working group Molecular Pathology. Pathologe, 37. S. 249 - 253. NEW YORK: SPRINGER. ISSN 1432-1963
Janning, M., Sueptitz, J., Albers-Leischner, C., Delpy, P., Tufman, A., Velthaus-Rusik, J-L, Reck, M., Jung, A., Kauffmann-Guerrero, D., Bonzheim, I, Braendlein, S., Hummel, H-D, Wiesweg, M., Schildhaus, H-U, Stratmann, J. A., Sebastian, M., Alt, J., Buth, J., Esposito, I, Berger, J., Toegel, L., Saalfeld, F. C., Wermke, M., Merkelbach-Bruse, S., Hillmer, A. M., Klauschen, F., Bokemeyer, C., Buettner, R., Wolf, J. and Loges, S. (2022). Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNuM). Ann. Oncol., 33 (6). S. 602 - 616. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Ortiz-Bruechle, N., Muders, M., Toma, M., Esposito, I, Hartmann, A., Stoehr, R., Reis, H., Wild, P., Koellermann, J., Bremmer, F., Leichsenring, J., Stenzinger, A., Merkelbach-Bruse, S., Kirfel, S., Perner, S., Hartmann, N., Roth, W., Jung, A., Kirchner, T., Schwamborn, K., Pfarr, N., Dahl, E., Knuechel, R. and Gaisa, N. T. (2020). Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group. Urologe, 59 (3). S. 318 - 326. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Schwarz, C., Schulte-Hubbert, B., Bend, J., Abele-Horn, M., Baumann, I., Bremer, W., Brunsmann, F., Dieninghoff, D., Eickmeier, O., Ellemunter, H., Fischer, R., Grosse-Onnebrink, J., Hammermann, J., Hebestreit, H., Hogardt, M., Huegel, C., Hug, M., Illing, S., Jung, A., Kahl, B., Koitschev, A., Mahlberg, R., Mainz, J. G., Mattner, F., Mehl, A., Moeller, A., Muche-Borowski, C., Nuesslein, T., Puderbach, M., Renner, S., Rietschel, E., Ringshausen, F. C., Schmidt, S., Sedlacek, L., Sitter, H., Smaczny, C., Tuemmler, B., Vonberg, R., Wielpuetz, M. O., Wilkens, H., Wollschlaeger, B., Zerlik, J., Dueesberg, U. and van Koningsbruggen-Rietschel, S. (2018). CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa. Pneumologie, 72 (5). S. 347 - 393. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790